BTK and glioblastoma: Nestin, an important neural stem cell marker and EMT indicator, has been shown to be highly expressed in GBM patients with increased stemness and associated with a poor prognosis [16, 17]; Nestin was also significantly suppressed in Btk-silenced GBM cells.